Chrysin: Perspectives on contemporary status and future possibilities as pro‐health agent

Abstract

Chrysin belongs to the group of natural polyphenols. It can be found, among others, in honey, propolis and fruits and has a wide range of biological activities, including the prevention of oxidative stress, inflammation, neurodegeneration and carcinogenesis. Being a part of the human diet, chrysin is considered to be a promising compound to be used in the prevention of many dis-eases, including cancers, diabetes and neurodegenerative diseases such as Alzheimer’s or Parkin-son’s. Nevertheless, due to the low solubility of chrysin in water and under physiological condi-tions, its bioavailability is low. For this reason, attempts at its functionalization have been under-taken, aiming to increase its absorption and thus augment its in vivo therapeutic efficacy. The aim of this review is to summarize the most recent research on chrysin, including its sources, metabo-lism, pro‐health effects and the effects of its functionalization on biological activity and pharmacological efficacy, evaluated both in vitro and in vivo.